Summary Vitamin D deficiency is highly prevalent all over the world and dietary intakes of vitamin D are very low in China. In this study we aimed to determine whether vitamin D deficiency is associated with increased risk of metabolic syndrome (MetS) among Chinese type 2 diabetes mellitus (T2DM) patients aged over 50 y. Vitamin D deficiency is now an increasingly recognized worldwide health concern (1) related to its nonclassical roles, such as diabetes, heart disease, autoimmune diseases and certain types of cancers. Low serum 25-hydroxyvitamin D [25(OH)D] concentrations are also deemed to be related to the high incidence of type 2 diabetes mellitus (T2DM) (2) because of existing vitamin D receptors on pancreatic b cells and the other insulin-sensitive tissue such as skeletal muscle tissue. Outcomes indicated that fasting plasma glucose (FPG) and the insulin sensitive index improved significantly in a study of vitamin D supplementation for patients with T2DM (3). The elderly are at high risk for vitamin D deficiency worldwide. And it is worth noting that the prevalence of T2DM is 11.6% with 50.1% of pre-diabetes (IGT) among adults over 18 y in China according to the latest international clinical diagnostic criteria (HbA1c $6.5%). The burden from T2DM complications and mortality is higher in worldwide.
Vitamin D deficiency is now an increasingly recognized worldwide health concern (1) related to its nonclassical roles, such as diabetes, heart disease, autoimmune diseases and certain types of cancers. Low serum 25-hydroxyvitamin D [25(OH)D] concentrations are also deemed to be related to the high incidence of type 2 diabetes mellitus (T2DM) (2) because of existing vitamin D receptors on pancreatic b cells and the other insulin-sensitive tissue such as skeletal muscle tissue. Outcomes indicated that fasting plasma glucose (FPG) and the insulin sensitive index improved significantly in a study of vitamin D supplementation for patients with T2DM (3). The elderly are at high risk for vitamin D deficiency worldwide. And it is worth noting that the prevalence of T2DM is 11.6% with 50.1% of pre-diabetes (IGT) among adults over 18 y in China according to the latest international clinical diagnostic criteria (HbA1c $6.5%). The burden from T2DM complications and mortality is higher in worldwide.
The metabolic syndrome (MetS) is commonly characterized by dyslipidemia, dysglycemia, abdominal obesity and hypertension (4) . MetS is associated with an increased risk of T2DM and cardiovascular complications, and is a complex of interrelated risk factors for diabetes (5) . We know that obesity is also one of the risk factors for vitamin D deficiency, because the excess fat absorbs and holds onto the vitamin D so that it cannot be used for bone building or cellular health. The elderly are at high risk for vitamin D deficiency worldwide due to reduced ability of active vitamin D synthesis. Moreover, relationships among serum 25(OH)D and dyslipidemia, abdominal obesity, and hypertension have been explored in different regions and various kinds of people (6) (7) (8) , but data to support those relationships are inconsistent with only a sparse sample from Asian people with T2DM. In addition to these traditional risk factors, some blood biomarkers such as apolipoprotein (Apo) A1 and ApoB (9), C-reactive protein (CRP), fibrinogen, and homocysteine (10-12), and vitamin D status (13) (14) (15) have been proposed to be involved in its pathogenesis. Previous studies have indicated that low concentrations of serum 25(OH)D may be associated with an increased risk of MetS (8, 16, 17) , but whether this association exists among T2DM patients remains unclear. Thus, the aim of our study was to determine whether vitamin D deficiency is associated with increased risk of MetS among Chinese patients with T2DM aged over 50 y.
MATERIALS AND METHODS
Survey and sample. Data collection took place in Lishui (latitude: 28°N), a city of Zhejiang Province, southeast China. A combination of stratified and random sampling methods was adopted and 283 participants aged 50 y and older with a previous diagnosis of T2DM according to the diabetes diagnostic criteria set by the WHO in 1998 (18) were recruited from the Center of Disease Control and Prevention (CDC). People were excluded in the case of a predicted survival of less than 3 y, prior history of diabetic ketosis or ketoacidosis, hypertonic coma, renal calculi, corticosteroid use, calcitriol or calcium use, or other serious complications of diabetes.
The study was approved by the Ethics Committee of Soochow University (ESCU-20160001), and it was in compliance with the declaration of Helsinki with all subjects providing written informed consent before participating in the study.
Data collection. In a community interview, a predesigned questionnaire was administered by trained research assistants to collect information regarding demographic characteristics, lifestyle risk factors (including smoking, alcohol drinking and recreational physical activity) as well as disease history and medication intake. After that, all participants were invited to attend a clinical examination after an overnight fast. We measured the height, weight, waist and hip circumference, and blood pressure of each subject at the baseline visit without hat and shoes.
Assessment of biomarkers. Peripheral venous blood specimens were collected in separation gel coagulation promoting tubes from all participants according to a pre-protocol. They were instructed to fast for 12 h until the early morning before blood collection, take all regular medications except for diabetes medication, take no aspirin or nonsteroidal anti-inflammatory drugs for 48 h before the visit except for those medications taken regularly. Circulating levels of 25(OH)D are considered to be the most reliable measure of overall vitamin D status (19) . Serum 25(OH)D levels were measured with an electrochemical luminescence system, COBAS e601 (Roche Diagnostics Gmbh, Mannheim, Germany). Vitamin D nutritional status was assessed as "sufficiency" ($30 ng/mL), "insufficiency" [20 ng/mL#25(OH)D ,30 ng/mL], or "deficiency" (,20 ng/mL) (20) . FPG was measured in serum by using the hexokinase method on an automatic biochemical analyzer called COBAS c702 (Roche Diagnostics Gmbh). The total triglycerides (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) concentrations were measured enzymatically on the same machine. Plasma high-sensitive C-reactive protein (hs-CRP), and glycosylated hemoglobin (HbA1c) were measured by the immunoturbidimetric method (Ultrasensitive CRP kit; Roche Diagnostics Gmbh). Insulin was determined by the electrochemical luminescence system with COBAS e601.
The homeostatic model assessment of insulin resistance (HOMA-IR) was computed by using the formula:
[Fasting plasma insulin (mU/L) * fasting glucose (mmol/L)]422.5
(1) The homeostatic model assessment of b cell function (HOMA-b) was calculated as follows (21, 22) :
(2) All of the intra-and interassay coefficients of variation were ,13%.
Definition of metabolic syndrome. MetS was defined using the updated guidelines proposed for Chinese by the International Diabetes Federation and the American Heart Association/National Heart, Lung, and Blood Institute (5) Statistical analysis. According to the tertile range of serum 25(OH)D concentrations, subjects were assigned to the "Tertile 1 ($25 ng/mL)," "Tertile 2 (19-25 ng/ mL)" and "Tertile 3 (0-19 ng/mL)" group, respectively. We described the demographic characteristics and risk factors with mean and standard deviation (SD) for continuous variables, and for the non-normal distribution data with median and quartiles, as well as for the classification variables with rate. 25(OH)D, FPG, TG, HDL-C, TG/HDL-C, insulin, HOMA-b and HOMA-IR were log-transformed before analysis in the case of skewed distribution. In addition, we performed logistic regression analysis to generate the odds ratios (ORs) and 95% confidence intervals (95% CI) of the prevalence of MetS across tertiles of serum 25(OH)D concentrations in the sample of patients with T2DM for which model 1 was unadjusted. In order to further adjust the confounding factors, we then adjusted for age, gender, residential region (urban/rural) and calcium supplement (yes/no) (model 2). After that, we adjusted for insulin, HOMA-IR and inflammatory factor (hs-CRP) based on model 2 (model 3). Further adjustments were made for the BMI (model 4). In stratified analyses, we assessed the potential effect modification by BMI (, or $24 kg/m 2 ). Each corresponding change in ORs and 95% CI of MetS for each 10 ng/mL decrease in the serum 25(OH)D concentrations was calculated. Furthermore, to model the shape of the dose-response relation between serum 25(OH)D and MetS, the association was also evaluated with the use of nonparametric restricted cubic splines, with 3 knots defined at the 10th, 50th, and 90th percentiles of the distribution of 25(OH)D. A p value of less than 0.05 indicated statistical significance. All the statistical analyses were performed with SAS software (version 9.2; SAS Institute, Cary, NC).
RESULTS
In our study including 270 subjects with T2DM, the percentages of vitamin D deficiency and insufficiency reached 43.71% and 39.63%, respectively, while the percentage of vitamin D sufficiency was only 16.66%. The characteristics of subjects are summarized in Table  1 . There was no significant difference among three groups for age, region or calcium supplementation, except for gender. However, compared with Tertile 1 groups, the indicators for metabolic profiles (such as waist circumference, hipline circumference, BMI, SBP, and TG) and insulin resistance (insulin and HOMA-IR) were significantly higher, and the higher degree of vitamin D deficiency showed a higher trend of related-indicators. Inversely, the level of HDL-C was lower (p,0.05).
Serum 25(OH)D concentrations were significantly lower in subjects with MetS than in those without MetS (21.74 vs 24.96 ng/mL, p50.001) ( Table 2 ). As shown in Table 3 The relationship between T2DM and vitamin D deficiency has been extensively reported (2, 24) . Vitamin D supplementation has been shown to improve, and even prevent, type 2 diabetes mellitus in both human (3) and animal models (25) . MetS is a complex of interrelated risk factors in the progression of T2DM, and whether it is associated with vitamin D status has been a widespread concern.
Findings from a general population have also shown an association between serum 25(OH)D level and the risk of MetS. For example, a prospective study carried out in Denmark brought in 4,330 individuals aged 30-60 y, with a 5-y follow-up, and revealed that serum 25(OH)D levels were inversely associated with incidence rates of MetS and hypercholesterolemia, and the ORs per 10 nmol/L higher baseline vitamin D level were 0.95 (p,0.05) and 0.94 (p50.01) for the development of the MetS and hypercholesterolemia, respectively (23) . Recently, a study in middle-aged and older Korean adults also reported that serum 25(OH)D concentrations were inversely associated with the risk of MetS after adjusting for confounding factors (ptrend50.0163) (26) . In contrast, a previous investigation in Korean adults aged $19 y showed that there was no association between serum 25(OH)D and MetS (27) . However, there was no research focus on the relationship between vitamin D and MetS among elderly patients with T2DM. These relationships may be affected by the extraordinarily high levels or the differences in the age of participants and sample collection period (over four seasons). Thus, randomized controlled trials of vitamin D supplementation in older adults are warranted to determine whether this association is causal and reversible. Several mechanisms may explain how vitamin D affects the risk of MetS. Firstly, the serum TG may be affected by vitamin D through an increase of intestinal calcium absorption; it may ultimately reduce hepatic TG formation and/or secretion via an effect on hepatocellular calcium (28, 29) . In addition, vitamin D could modulate lipid levels via suppression of PTH secretion, as elevated PTH concentrations reportedly reduce lipolysis (30) . Secondly, the blood pressure may be influenced by vitamin D through regulation of the renin-angiotensin system, an important regulator of blood pressure (31, 32) . Last, experimental studies have suggested that vitamin D may exert its beneficial effects by stimulating the expression of an insulin receptor to improve insulin responsiveness for glucose transport or by controlling calcium influx, which is essential for the insulin-mediated intracellular process in insulin-responsive tissues (33) .
There are several limitations to this study. Firstly, it was impossible to prove a causal relationship due to the nature of the cross-sectional design. Secondly, the small sample size may affect the stability of the results. Thirdly, 4.6% of the recruited individuals did not participate in the study because they were away from home or refused to respond, which may have caused selection bias. Despite these limitations, to the best of our knowledge, this is the first study to investigate the association of serum 25(OH)D status with MetS in Chinese middleaged and elderly patients with T2DM.
In summary, our findings suggested that serum 25(OH)D concentrations were inversely associated with the risk of MetS among the middle-aged and elderly 
